Xenetic Biosciences (XBIO) Non-Current Debt (2011 - 2013)
Xenetic Biosciences' (XBIO) quarterly Non-Current Debt came in at $160000.0 in Q4 2013, down 24.82% YoY from $212813.0 in Q4 2012, and down 24.82% on a QoQ basis from $212813.0 in Q3 2013.
Xenetic Biosciences (XBIO) Non-Current Debt (2011 - 2013) Analysis & Trends
Xenetic Biosciences (XBIO) has 3 years of Non-Current Debt data on file, last reported at $160000.0 in Q4 2013.
- Quarterly Non-Current Debt fell 24.82% year-over-year to $160000.0 in Q4 2013, while the trailing twelve-month figure through Nov 2013 was $160000.0 (down 24.82% YoY) and the FY2013 annual result came in at $212813.0, changed 0.0% from the prior year.
- Non-Current Debt eased to $160000.0 in Q4 2013, from $212813.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $212813.0 in Q3 2011 to a low of $160000.0 in Q4 2013.
- A 3-year average of $206944.9 and a median of $212813.0 in 2011 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2012 — Non-Current Debt changed 0.0% — and 2013, when it slipped 24.82%.
- Tracing XBIO's Non-Current Debt over 3 years: stood at $212813.0 in 2011, then changed by 0.0% to $212813.0 in 2012, then retreated by 24.82% to $160000.0 in 2013.
- The last three Non-Current Debt figures came in at $160000.0 (Q4 2013), $212813.0 (Q3 2013), and $212813.0 (Q2 2013), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Xenetic Biosciences | 7.59 Mn | 1.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2013 | 160,000.00 |
| Aug 31, 2013 | 212,813.00 |
| May 31, 2013 | 212,813.00 |
| Feb 28, 2013 | 212,813.00 |
| Nov 30, 2012 | 212,813.00 |
| Aug 31, 2012 | 212,813.00 |
| May 31, 2012 | 212,813.00 |
| Feb 29, 2012 | 212,813.00 |
| Aug 31, 2011 | 212,813.00 |